Small doses of subcutaneous sodium heparin in the prevention of deep vein thrombosis after elective hip operations

Abstract
The efficacy of small perioperative doses of subcutaneous heparin in preventing deep vein thrombosis has been studied in a controlled clinical trial on 64 patients undergoing elective hip surgery. The results indicate that the regimen of sodium heparin used was safe provided that the correct dose is given. It reduced the frequency of postoperative deep vein thrombosis from 37 to 7 per cent.
Funding Information
  • Board of Governors of St Mary's Hospital
  • Pfizer Ltd
  • Weddel Pharmaceuticals Ltd